1. Home
  2. PD vs NVCR Comparison

PD vs NVCR Comparison

Compare PD & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$12.97

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$12.63

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PD
NVCR
Founded
2009
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
PD
NVCR
Price
$12.97
$12.63
Analyst Decision
Buy
Buy
Analyst Count
10
6
Target Price
$17.70
$28.42
AVG Volume (30 Days)
3.2M
1.9M
Earning Date
11-25-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.63
N/A
Revenue
$489,207,000.00
$642,269,000.00
Revenue This Year
$8.21
$9.75
Revenue Next Year
$4.33
$5.62
P/E Ratio
$7.86
N/A
Revenue Growth
7.01
11.17
52 Week Low
$11.13
$10.70
52 Week High
$20.05
$34.13

Technical Indicators

Market Signals
Indicator
PD
NVCR
Relative Strength Index (RSI) 42.85 51.80
Support Level $12.55 $12.30
Resistance Level $13.24 $13.94
Average True Range (ATR) 0.37 0.66
MACD 0.13 0.07
Stochastic Oscillator 80.86 58.41

Price Performance

Historical Comparison
PD
NVCR

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: